(+/-)-CEPHALOTAXINE
Compound with spectra: 2 NMR
| SpectraBase Compound ID | 3v7Zyt6fBtb |
|---|---|
| InChI | InChI=1S/C18H21NO4/c1-21-15-9-18-4-2-5-19(18)6-3-11-7-13-14(23-10-22-13)8-12(11)16(18)17(15)20/h7-9,16-17,20H,2-6,10H2,1H3/t16-,17-,18+/m1/s1 |
| InChIKey | YMNCVRSYJBNGLD-KURKYZTESA-N |
| Mol Weight | 315.37 g/mol |
| Molecular Formula | C18H21NO4 |
| Exact Mass | 315.147058 g/mol |
| Enantiomer InChIKey | YMNCVRSYJBNGLD-OKZBNKHCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C6D6 |
- Cephalotaxine
5-(3-methoxyphenyl)-8,8-dimethyl-2-[(4-pyridinylmethyl)sulfanyl]-5,8,9,10-tetrahydropyrimido[4,5-b]quinoline-4,6(3H,7H)-dione
9,14b-Dihydro-4H-cyclopenta[a][1,3]dioxolo[4,5-H]pyrrolo[2,1-b][3]benzazepine-1,6(5H,8H)-dione
(-)-AMARBELLISINE
Silane, [[(3.beta.,5.alpha.)-4,4-dimethylcholesta-8,24-dien-3-yl]oxy]trimethyl-
5-Benzo[1,3]dioxol-5-yl-6-tert-butoxy-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-ol
(8S,9S,11S,13S,14S,16S,17R)-2-fluoranyl-11-methoxy-3-(methoxymethoxy)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16,17-diol
1-Aza-1-benzyl-6-[2'-(2-(benzyloxy)ethyl)-4',5'-(methylenedioxy)phenyl]-7-(pivaloyloxy)spiro[4.4]non-6-ene
(-)-STENANTHERINE
N-Ethyl-Laurolitsine
N-Tosyl-2,3,4,12b-tetrahydro-7,10,11-trimethoxy-1H-[1]benzopyrano[4,3,2-ef][3]benzazepine
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis via vinyl sulfones. 38. Total synthesis of the cephalotaxus alkaloids dl-cephalotaxine, dl-11-hydroxycephalotaxine, and dl-drupacine | Journal of the American Chemical Society | 1990 |
| Carbon-13 nuclear magnetic resonance spectroscopy of cephalotaxus alkaloids | Organic Magnetic Resonance | 1980 |